Staphylococcus Aureus Panton-Valentine Leukocidin causing hip osteomyelitis, thrombophlebitis and necrotizing

M S Cori1, G Ronconi2, E Masiello1

  • 1Pediatric Institute Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome Italy.

Insights

Panton-Valentine leukocidin (PVL) is a dangerous toxin from Staphylococcus aureus. This case highlights severe PVL-associated osteomyelitis in a child, stressing the need for early recognition and management.

Area of Science:

  • Microbiology
  • Toxicology
  • Infectious Diseases

Background:

  • Panton-Valentine leukocidin (PVL) is a key virulence factor in Staphylococcus aureus, responsible for leukocyte destruction and tissue necrosis.
  • PVL-producing Staphylococcus aureus (PVL-SA) infections, particularly osteomyelitis, pose significant clinical challenges.
  • Data on PVL-SA prevalence in Italy are limited, potentially leading to under-recognition.

Observation:

  • A pediatric case of hip joint osteomyelitis with associated thrombophlebitis, necrotizing pneumonia, and septic shock is presented.
  • The patient required extensive intensive care unit (ICU) support, including mechanical ventilation and circulatory support.
  • Management involved surgical drainage and prolonged second-line antibiotic therapy.

Findings:

  • The case underscores the severe complications associated with PVL-SA osteomyelitis in children.
  • Over half of PVL-SA strains in Europe are Methicillin-Susceptible Staphylococcus Aureus (MSSA), complicating initial treatment decisions.
  • Diagnostic challenges exist due to the variable availability of PVL testing.

Implications:

  • Early recognition of clinical features suggestive of PVL-SA osteomyelitis in pediatric patients is crucial.
  • Prompt and adequate management, including appropriate antibiotic selection and surgical intervention, is vital for patient outcomes.
  • Further epidemiological studies on PVL-SA prevalence in Italy are needed to guide clinical practice and public health strategies.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
675
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
637
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
185
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
583
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
267